Deals
Medical-Laser Maker Cynosure Said to Eye Sale Amid Review
- Cynosure said to hold talks with financial advisers on options
- Sale may draw interest from large, global firms like Allergan
This article is for subscribers only.
Cynosure Inc., the maker of lasers for medical and cosmetic treatments, is exploring strategic options including a sale, according to people familiar with the matter, amid increasing interest in the technology from larger global companies.
Cynosure is in talks with financial advisers as it weighs strategic options, the people said, asking not to be identified because the deliberations are private. A potential sale of the business, which has a market value of about $1 billion, may attract companies with a presence in aesthetic treatments, such as Botox maker Allergan Plc, as well as other medical-device businesses, the people said.